Live Breaking News & Updates on Fabian Grein|Page 2
Stay updated with breaking news from Fabian grein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
<p><strong>Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers at the University Hospital Bonn (UKB), the University of Bonn and the German Center for Infection Research (DZIF) have discovered a new so-called lantibiotic, namely epilancin A37. It is produced by staphylococci that colonize the skin and acts specifically against their main competitors there, the corynebacteria. This specificity is presumably mediated by a very special mechanism of action, which the researchers were able to decipher in detail. Their results have now been published in the renowned ISME Journal.</strong></p> ....
A cooperation between the University of Bonn, the USA, and the Netherlands cracks the mode of action of clovibactin. The rise in bacterial pathogens with resistance is alarming. Common medications are at a growing risk of becoming ineffective against infectious diseases. Consequently, global scient ....
We still do not understand exactly how antibiotics kill bacteria. However, this understanding is necessary if we want to develop new antibiotics. And that is precisely what is urgently needed, because bacteria are currently showing more and more resistance to existing antibiotics. Therefore, researchers from the University Hospital Bonn (UKB) and the University of Bonn used high-performance microscopes to observe the effect of different antibiotics on the cell division of Staphylococcus aureus. They found that the biosynthesis of peptidoglycan, core component of the bacterial cell wall, is the driving force during the entire process of cell division. In addition, they clarified how exactly different antibiotics block cell division within a few minutes. The results have now been published in the journal Science Advances. ....